ArticleThe Journal of biological chemistry2026
PFOS-induced mitochondrial ROS impairs male reproductive function by suppressing FTO-dependent m
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Perfluorooctanesulfonic acid (PFOS), a persistent per- and polyfluoroalkyl substance, has been associated with male reproductive toxicity, but the underlying molecular mechanisms remain incompletely defined. Here, we show that chronic exposure to environmentally relevant doses of PFOS caused dose-dependent testicular injury and spermatogenic dysfunction in mice, as indicated by reduced testis weight, disrupted seminiferous tubule architecture, and impaired sperm quality. Transcriptomic profiling revealed marked enrichment of pathways related to oxidative stress, mitochondrial dysfunction, and reproductive regulation. Mechanistically, PFOS increased mitochondrial reactive oxygen species (ROS) production in GC-2 spermatocyte cells, leading to mitochondrial membrane potential collapse, lipid peroxidation, and depletion of antioxidant defenses. Pharmacological scavenging of mitochondrial ROS with Mito-TEMPO attenuated PFOS-induced mitochondrial injury in vitro and improved testicular damage and sperm quality in vivo. We further found that PFOS suppressed the RNA demethylase fat mass and obesity-associated protein (FTO) and promoted its ROS-dependent redistribution from the nucleus to mitochondria, resulting in global N6-methyladenosine (m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.